Sauer Paul 4
4 · Vaxcyte, Inc. · Filed Aug 24, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Sale
Common Stock
2022-08-22$25.93/sh−3,000$77,785→ 14,687 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.685 to $26.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.